Document is current
Any future updates will be listed below
-
Authors
Chapman, Fiona A.
Melville, Vanessa
Godden, Emily
Morrison, Beth
Bruce, Lorraine
Maguire, Janet J. https://orcid.org/0000-0002-9254-7040
Davenport, Anthony P. https://orcid.org/0000-0002-2096-3117
Newby, David E. https://orcid.org/0000-0001-7971-4628
Dhaun, Neeraj https://orcid.org/0000-0001-9128-6603
- License Information
-
More Information
Article History
Received: 21 March 2024
Accepted: 9 September 2024
First Online: 14 October 2024
Competing interests
: D.E.N. has historically received consultancy fees from Bristol-Myers Squibb and Amgen regarding the development of apelin receptor agonists for heart failure and was a sub-investigator in a clinical trial for Bristol-Myers Squibb (NCT03281122). All other authors have no competing interests.
